Literature DB >> 9046952

Paraneoplastic syndromes affecting the central nervous system.

J B Posner1, J O Dalmau.   

Abstract

Paraneoplastic syndromes affecting the nervous system are rare neurologic syndromes caused by cancer but not ascribable to metastases. Any portion of the nervous system may be involved in a paraneoplastic syndrome. The pathogenesis of these disorders appears to be an immune reaction against antigens shared by the cancer and the nervous system. Some disorders, such as the Lambert-Eaton myasthenic syndrome, are effectively treated by removal of autoantibodies directed against the presynaptic cholinergic synapse. In other disorders, such as paraneoplastic cerebellar degeneration or paraneoplastic sensory neuronopathy, neither removal of the autoantibody nor treatment of the cancer is effective.

Entities:  

Mesh:

Substances:

Year:  1997        PMID: 9046952     DOI: 10.1146/annurev.med.48.1.157

Source DB:  PubMed          Journal:  Annu Rev Med        ISSN: 0066-4219            Impact factor:   13.739


  5 in total

1.  LP-BM5 virus-infected mice produce activating autoantibodies to the AMPA receptor.

Authors:  E Koustova; Y Sei; L Fossom; M L Wei; P N Usherwood; N B Keele; M A Rogawski; A S Basile
Journal:  J Clin Invest       Date:  2001-03       Impact factor: 14.808

2.  Progress in the management of paraneoplastic neurological disorders.

Authors:  Hamid Sadeghian; Steven Vernino
Journal:  Ther Adv Neurol Disord       Date:  2010-01       Impact factor: 6.570

3.  Autoantibody responses in Chinese hepatocellular carcinoma.

Authors:  Jian-Ying Zhang; Xiao Wang; Xuan-Xian Peng; Edward K L Chan
Journal:  J Clin Immunol       Date:  2002-03       Impact factor: 8.317

Review 4.  Genetic association, seasonal infections and autoimmune basis of narcolepsy.

Authors:  Abinav Kumar Singh; Josh Mahlios; Emmanuel Mignot
Journal:  J Autoimmun       Date:  2013-03-13       Impact factor: 7.094

5.  Expression of amphiphysin I, an autoantigen of paraneoplastic neurological syndromes, in breast cancer.

Authors:  S Floyd; M H Butler; O Cremona; C David; Z Freyberg; X Zhang; M Solimena; A Tokunaga; H Ishizu; K Tsutsui; P De Camilli
Journal:  Mol Med       Date:  1998-01       Impact factor: 6.354

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.